Fmoc-NH-PEG8-NHS

pDMAPS；Poly (2-(N-3-Sulfopropyl-N,N-dimethyl ammonium)ethyl methacrylate)

21,39-di-tert-butyl 1-(2,5-dioxopyrrolidin-1-yl) (S)-9,18,23-trioxo-2,5,11,14-tetraoxa-8,17,22-triazanonatriacontane-1,21,39-tricarboxylate

4-arm Poly(ethylene glycol) succinimidyl carbonate  (4-arm PEG-SC) is available with molecular weight 2K, 5K, 10K, 20K and 40K Da, other M.W. may be available by custom synthesis. The packaging sizes are available for 1g, 10g and 100g. Please contact us for bulk and GMP grade PEGs pricing and pac...

α,ω-Diacryloyl poly(ethylene glycol) (AA-PEG-AA) is available with molecular weight 2K, 5K, 10K, 20K and 40K Da, other M.W. may be available by custom synthesis. The packaging sizes are available for 1g, 10g and 100g. Please contact us for bulk and GMP grade PEGs pricing and packaging size. MW 2000 Da...

Ac-GalNAc-Cluster-Hyp-SA

α-galnac-ω-distearoyl-sn-glycero-3-phosphoethanolamino poly(ethylene glycol)

Galnac

Amino-PEG8-t-butyl ester

(S)-16-((1-(tert-butoxy)-5-((2,5-dioxopyrrolidin-1-yl)oxyl)-1,5-dioxopentan-2-yl)amino)-16-oxohexadecanoic acid

1-(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) (22-(tert-butoxy)-22-oxodocosanoyl)-L-glutamate

Methoxypoly(ethylene glycol) amine  (mPEG-NH2) is critical PEG material for PEGylated drug.
Methoxypoly(ethylene glycol) amine (mPEG-NH2) is formed by a degradable linker connecting PEG polymer chain and theamine, which is reactive with amine on protein. SINOPEG offers mPEG-NH2 with molecular...

Azido-PEG8-amine

Xiamen Sinopeg Biotech Co., Ltd. is dedicated to drug delivery systems and related medical device business, focusing on the research, development, production, and sales of high-end drug delivery carriers/auxiliary materials/APIs, medical materials, including but not limited to polyethylene glycol derivatives, lipid products, blood sugar control drug modifiers, block copolymers, ADC/ProTAC linkers, biodegradable polymers, exosomes, viral-like particles, as well as providing CDMO and solution services. These products are widely used in long-acting protein/peptide drugs, COVID-19 mRNA vaccines, small nucleic acid drugs, blood sugar control drugs, macromolecular micelle drugs, liposome drugs, gene therapy drugs, immunosuppressants, ADC drugs, ProTAC drugs, medical hydrogels, and other fields, placing the company in a leading position in the industry.